Prakt. lékáren. 2011; 7(1): 39-41
Alzheimer's disease is a progressive neurodegenerative process which affects a significant proportion of the population, particularly those
over 65 years of age. The disease is associated with deficits and disorders of a number of neurotransmitter systems, in particular the
cholinergic one. Currently, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors appear to be the most promising
therapeutic agents. Even among naturally occurring compounds, there are inhibitors of these enzymes and many of them are more
effective than those used in the medical practice. For instance, huperzine A has more profound effects and exhibits more beneficial
pharmacokinetic properties than current medications.
Published: February 1, 2011 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...